Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DPV-001 Vaccine in Stage IIIA/IIIB NSCLC
NCT01909752Phase 2Completed
- Sponsor
- UbiVac
- Start
- Jul 2013
- Primary completion
- Nov 2016
- Modality
- Whole Cell Cancer Vaccines, Oncolytic Viruses, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of DPV-001 in non-small cell lung cancer (NSCLC), sponsored by UbiVac. Started Jul 2013; status: completed.
02
Drugs
DPV-001
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01909752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01909752.